We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M Turnover 12.28%
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$479M
AUM Growth
+$9.48M
Cap. Flow
-$10.4M
Cap. Flow %
-2.18%
Top 10 Hldgs %
47.36%
Holding
54
New
1
Increased
8
Reduced
11
Closed
3
Avg Time Held
5.8 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
4.6 years

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.23M
2
VLTO icon
Veralto
VLTO
+$1.9M
3
ALC icon
Alcon
ALC
+$1.73M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$371K
5
APTV icon
Aptiv
APTV
+$356K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.71M
2
NKE icon
Nike
NKE
+$7.44M
3
AAPL icon
Apple
AAPL
+$1.88M
4
SJM icon
J.M. Smucker
SJM
+$214K
5
PG icon
Procter & Gamble
PG
+$123K

Sector Composition

Rank Sector Weight
1 Technology 34.49%
2 Industrials 19.13%
3 Healthcare 16.54%
4 Consumer Discretionary 10.76%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PFE icon
51
Pfizer
PFE
$168B
$686K 0.14%
24,500
– –
2015 Q4
34 quarters
CVS icon
52
CVS Health
CVS
$118B
– –
-96,605
Closed -$7.71M –
NKE icon
53
Nike
NKE
$55.3B
– –
-79,115
Closed -$7.44M –
SJM icon
54
J.M. Smucker
SJM
$13.5B
– –
-1,700
Closed -$214K –
1 2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $621M AUM 14.19% 1-Year Est. Return

Chad R. Baker's Q2 2024 Portfolio in Review

As of Q2 2024, Chad R. Baker held 54 positions worth $479M, up 2% from $470M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Chad R. Baker's Q2 2024 filing shows 1 new, 8 increased, 11 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 5,145 shares worth $2.41M. The largest sale was CVS Health, an estimated $7.71M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

  • Chad R. Baker's largest Q2 2024 buy was Vertex Pharmaceuticals: 5,145 shares worth $2.41M.
  • Chad R. Baker added most to Veralto in Q2 2024, an estimated $1.9M increase.
  • Chad R. Baker's biggest Q2 2024 reduction was Apple, cutting an estimated $1.88M.
  • Chad R. Baker fully exited CVS Health in Q2 2024, selling an estimated $7.71M.
  • Chad R. Baker's ten largest holdings make up 47% of its $479M portfolio in Q2 2024.
  • Chad R. Baker opened 1 new position and closed 3 in Q2 2024.
  • Chad R. Baker's portfolio value rose 2% quarter-over-quarter to $479M.

Based on Chad R. Baker's 13F filing for Q2 2024, filed 22 Jul 2024.